As an innate immune inflammatory mediator, CRP has been extensively investigated in multiple neuropsychiatric disorders including MDD, anxiety, PTSD and schizophrenia for its potential as a biomarker (12–18). The gene discussed is CRP; the disease is major depressive disorder.